Interaction between carbamazepine, zonisamide and voltage-sensitive Ca2+ channel on acetylcholine release in rat frontal cortex

Epilepsy Research

Volumn 49, Issue 1, 2002, Pages 49-60

  Zhu, Gang ^a   Okada, Motohiro ^a   Murakami, Takuya ^a   Kawata, Yuko ^a   Kamata, Akihisa ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Carbamazepine; Epilepsy; Frontal cortex; Microdialysis; Zonisamide

Indexed keywords

ACETYLCHOLINE; ANTICONVULSIVE AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM ION; CARBAMAZEPINE; ZONISAMIDE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN PERFUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; ELECTRIC POTENTIAL; EVOKED RESPONSE; FRONTAL CORTEX; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION;

ACETYLCHOLINE; ANIMALS; CALCIUM CHANNELS; CARBAMAZEPINE; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FRONTAL LOBE; ISOXAZOLES; MALE; MICRODIALYSIS; RATS; RATS, WISTAR;

EID: 0036229384     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00015-3     Document Type: Article

References (48)

1. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy
2. Effects of muscarinic receptor agonists and antagonists on response of non-extensor rats to maximal electroshock
3. Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain
4. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy
5. Effects of carbamazepine on 5-hydroxytryptamine function in rodents
6. A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1
7. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy
8. Are some idiopathic epilepsies disorders of ion channels?: A working hypothesis
9. 1A receptor activation
10. Electroclinical picture of autosomal dominant nocturnal frontal lobe epilepsy in a Japanese family
11. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania
12. Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine dose not antagonize adenosine effect in vitro: Mechanisms of blockade of seizure spread
13. 2+ mobilization in rat hippocampus
14. +-evoked serotonin releases
15. Antiepileptic drugs-calcium current interaction in cultured human neuroblastoma cells
16. Mechanisms of T-type calcium channel blockade by zonisamide
17. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors
18. Microdialysis probes calibration: Gradient and tissue dependent changes in no net flux and reverse dialysis methods
19. Carbamazepine clinical use
20. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals
21. A mutation (Ser284Leu) of neural nicotinic acetylcholine receptor α4 subunit associated with frontal lobe epilepsy shows faster desensitization of the receptor
22. Carbamazepine
23. Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture
24. Effects of carbamazepine on acetylcholine release and metabolism
25. Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis
26. Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system
27. 2+ dependent dopamine release
28. Effects of zonisamide on dopaminergic system
29. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus
30. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis
31. 2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis
32. +, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode
33. Effects of carbamazepine on hippocampal serotonergic system
34. Biphasic effects of zonisamide on serotonergic system in rat hippocampus
35. Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release
36. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study
37. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy
38. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine
39. Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant
40. Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene
41. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder
42. Zonisamide
43. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy
44. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy
45. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
46. The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis
47. Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats
48. Action of eserine and prostigmin on epileptic cerebral discharges